BCL
IGC icon

Burnham & Co LLC’s IGC Pharma IGC Stock Holding History

Burnham & Co LLC’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.36K Buy
+5,000
New +$1.48K ﹤0.01% 193

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 4.87% 1-Year Est. Return

Burnham & Co LLC's IGC Position: Q2 2026 in Review

Burnham & Co LLC opened a new position in IGC Pharma (IGC) in Q2 2026: 5,000 shares worth $1.36K. The stake represents ﹤0.01% of the portfolio and ranks #193 among its holdings.

30 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Burnham & Co LLC held 5,000 shares of IGC Pharma worth $1.36K as of Q2 2026.
  • IGC Pharma was a new Burnham & Co LLC position in Q2 2026.
  • IGC Pharma made up ﹤0.01% of Burnham & Co LLC's portfolio in Q2 2026, its #193 holding.
  • 30 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Burnham & Co LLC's 13F filing for Q2 2026, filed 11 Aug 2026.